All articles tagged with #fibromyalgia
Originally Published 19 days ago — by Maryland Matters
A U.S. circuit court ruled that in cases like fibromyalgia, where no objective medical tests exist, subjective patient testimony must be given significant weight in disability benefit decisions, reversing a previous denial for a woman suffering from the condition and emphasizing the importance of recognizing such illnesses in the disability process.
Originally Published 2 months ago — by Earth.com
A large genetic study has identified 26 genetic regions linked to fibromyalgia, revealing that the condition primarily originates in the brain's neural circuits that control pain sensitivity, rather than in muscles or joints. The findings suggest fibromyalgia is related to nervous system hypersensitivity and shares genetic links with other disorders like chronic fatigue and PTSD, offering new avenues for early detection and targeted treatments.
Originally Published 2 months ago — by Medscape
Low-dose naltrexone (LDN), an old generic drug, is gaining attention as a promising off-label treatment for fibromyalgia, showing potential to reduce pain, fatigue, and brain fog, despite limited large-scale studies. Many patients and some doctors report significant benefits, and ongoing research suggests it may help manage symptoms by reducing nerve inflammation, though more rigorous trials are needed. It is often used as a last resort but could be considered earlier, with minimal side effects and low cost.
Originally Published 4 months ago — by Yahoo Finance
Tonix Pharmaceuticals' drug Tonmya has received FDA approval for treating fibromyalgia in adults, marking the first new therapy in over 15 years for this condition. The medication, a non-opioid, once-daily sublingual tablet, demonstrated significant pain reduction in clinical trials and is expected to be available in the US by late 2025.
Originally Published 4 months ago — by Investor's Business Daily
The FDA has approved Tonmya, a new treatment for fibromyalgia developed by Tonix Pharmaceuticals, marking the first new FDA-approved fibromyalgia drug in over 15 years. The drug is a once-daily sublingual tablet shown to significantly reduce pain in clinical trials. Following the announcement, Tonix's stock initially surged but then declined, reflecting market volatility and investor reactions.
Originally Published 5 months ago — by Stock Titan
Tonix Pharmaceuticals received FDA approval for Tonmya™, a non-opioid, sublingual tablet for fibromyalgia in adults, marking the first new treatment in over 15 years. The drug demonstrated significant pain reduction in Phase 3 trials and is expected to launch in Q4 2025, targeting over 10 million affected U.S. adults.
Originally Published 5 months ago — by LADbible
A woman with fibromyalgia experienced increased pain and inflammation after stopping Mounjaro, a medication she used for weight loss that also appeared to reduce her fibromyalgia symptoms, highlighting its potential anti-inflammatory effects beyond weight management.
Originally Published 6 months ago — by ScienceDaily
Researchers at the Salk Institute identified a new brain circuit involving CGRP neurons in the thalamus that mediates the emotional aspect of pain, challenging traditional views and offering potential new treatments for chronic pain and related psychiatric conditions like PTSD and migraines.
Originally Published 1 year ago — by KSL.com
Angie Ehrenzweig lost 100 pounds in one year after addressing underlying health issues like fibromyalgia, insulin resistance, and metabolic syndrome with the help of Dr. Whit Roberts at Health Utah. Her journey highlights the importance of resolving health problems before effective weight loss can occur. Health Utah offers comprehensive evaluations and personalized protocols to tackle such issues, emphasizing the need for a holistic approach to weight loss.
Originally Published 1 year ago — by KSL.com
Angie Ehrenzweig lost 100 pounds in a year with the help of Health Utah after struggling with fibromyalgia, extreme fatigue, insulin resistance, depression, systemic inflammation, and metabolic syndrome. Dr. Whit Roberts, D.C. ran a specialized scan and used a proprietary questionnaire to identify health problems contributing to her weight issues. The clinic's protocols addressed her conditions, including insulin resistance, through a combination of therapies, supplements, and dietary changes. Health Utah is offering a discounted weight loss package for two people to encourage support in weight loss journeys.
Originally Published 1 year ago — by Medical Xpress
Two recent studies from UT Health Austin provide crucial insights into long COVID, helping to define its symptoms and differentiate it from other conditions. One study found that long COVID patients experienced complex and disabling symptoms, with fatigue, "brain fog," and difficulty concentrating being the most common. Another study introduced a blood test that can accurately differentiate between long COVID and fibromyalgia, offering hope for quicker and more accurate diagnoses and targeted interventions. These findings aim to improve care for the millions of individuals still grappling with the long-term effects of the pandemic.
Originally Published 1 year ago — by The Washington Post
A woman shares her decades-long struggle with chronic fatigue syndrome (CFS) and fibromyalgia, detailing the dismissive treatment she received from doctors and the challenges of managing her symptoms. After years of misdiagnoses, she finally received a proper diagnosis and treatment plan from a specialist, allowing her to regain some level of functioning. The article also discusses the stigma attached to CFS and the recent attention it has received due to the similarities with long-covid, shedding light on the struggles faced by those with post-viral illnesses.
Originally Published 2 years ago — by KSL.com
Angie Ehrenzweig lost 100 pounds in a year with the help of Health Utah after struggling with fibromyalgia, extreme fatigue, insulin resistance, depression, systemic inflammation, and metabolic syndrome. Dr. Whit Roberts, D.C. used a specialized scan and questionnaire to identify her health issues and prescribed a personalized protocol for her care. The program addressed her conditions, including insulin resistance, through various methods such as herbal detoxification, supplements, infrared red light therapy, and dietary changes. Health Utah is offering a weight loss package for two people at a discounted rate to encourage support in health and weight loss journeys.
Originally Published 2 years ago — by Daily Mail
Researchers at Stanford University have discovered that electrical brain stimulation can make people more susceptible to hypnosis. By applying transcranial magnetic stimulation (TMS) to the prefrontal cortex, they found that participants with fibromyalgia became significantly easier to hypnotize, potentially improving the effectiveness of hypnosis as a treatment for chronic pain. The effect, however, was temporary, dissipating within an hour. This breakthrough could enhance pain management strategies for conditions like fibromyalgia, which affects millions of adults. The study's results were published in the journal Nature Mental Health.
Originally Published 2 years ago — by OregonLive
A 70-year-old woman with fibromyalgia expresses her struggle with the high cost of medications such as Lyrica, Cymbalta, and Savella, which are now out of her financial reach. Despite diet changes and exercise providing marginal relief, she finds herself without help and options for relief during flare-ups. Dr. Keith Roach, a physician, acknowledges the challenges faced by patients with fibromyalgia and emphasizes the importance of managing diet, exercise, and sleep. He suggests considering older and cheaper medications like tricyclic antidepressants, which can be more effective than newer options. Additionally, he recommends exploring prescription-drug savings programs like GoodRx or SingleCare, as well as the Cost Plus Drug Company online, to obtain medications at significantly reduced prices. However, he notes that newer and expensive drugs may not be available at such discounts through these programs.